We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche Executive: Trump’s ‘Most Favored Nations’ Policy is Overreaching
Roche Executive: Trump’s ‘Most Favored Nations’ Policy is Overreaching
A top Roche executive slammed President Trump’s expanded “most favored nations” executive order as an unwise and overreaching policy for reducing U.S. drug prices, contending that the president’s own economic advisers found foreign price comparisons would hinder access to new medicines.